T CELL RECEPTORS TARGETING MUTATED CDKN2A Read more about T CELL RECEPTORS TARGETING MUTATED CDKN2A US Application 63/381,591Filed on 2022-10-31
HUMAN PAPILLOMAVIRUS AND VARICELLA-ZOSTER VACCINE ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY Read more about HUMAN PAPILLOMAVIRUS AND VARICELLA-ZOSTER VACCINE ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY US Application 63/481,544Filed on 2023-01-25
PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES US Application 63/349,829Filed on 2022-06-07
Topoisomerase Ill (TOP3) inhibitors as antiviral and anticancer compounds based on bisacridines Read more about Topoisomerase Ill (TOP3) inhibitors as antiviral and anticancer compounds based on bisacridines US Application 63/429,923Filed on 2022-12-02
Synergistic Interactions For Improved Cancer Treatment Read more about Synergistic Interactions For Improved Cancer Treatment US Application 63/398,450Filed on 2022-08-16
Method Of Subtyping Of Small Cell Lung Cancer Using Plasma Cell-Free Nucleosomes Read more about Method Of Subtyping Of Small Cell Lung Cancer Using Plasma Cell-Free Nucleosomes US Application 63/342,763Filed on 2022-05-17
Single Domain Antibodies Targeting HPV E6/E7 Oncogenic Peptide/MHC Complexes Read more about Single Domain Antibodies Targeting HPV E6/E7 Oncogenic Peptide/MHC Complexes US Application 63/374,307Filed on 2022-09-01
Improving Heart Function Following Myocardial Infarction Using Anti-TEM8/ANTXR1 Antibodies Read more about Improving Heart Function Following Myocardial Infarction Using Anti-TEM8/ANTXR1 Antibodies US Application 63/448,198Filed on 2023-02-24
COMPOSITIONS, SYSTEMS, AND METHODS FOR DELIVERY OF THERAPEUTICS Read more about COMPOSITIONS, SYSTEMS, AND METHODS FOR DELIVERY OF THERAPEUTICS US Application 63/350,315Filed on 2022-06-08
FIRST SARS-COV-2 VACCINE IMMUNOGENS Read more about FIRST SARS-COV-2 VACCINE IMMUNOGENS US Application 63/351,196Filed on 2022-06-10